Journal Articles

  1. Sabz, M., MacLean, J., Martin, A.R., and Rouhani, H. (2024). "Characterization of wearable respiratory sensors for breathing parameter measurements." IEEE Sensors. 24(20): 32283-32290.

  2. Pillay, K., Finlay, W.H., and Martin, A.R. (2024). "Understanding regional aerosol deposition in pediatric airways during oral breathing: insights from computational modeling." Journal of Aerosol Science. 182: 106438 (13 pages).

  3. Abhyankar, M.M., Xu, F., Chavez, D., Goodroe, A., Mendoza, E., Chen, C., Singh, D.K., Varnador Jr., F., Sivananthan, S.J., Kinsey, R., Lykins, W.R., Murphy, B.M., Martin, A.R., Tomai, M.A., Ghosal, S., Casper, C., Pedersen, K., Petri Jr., W.A., and Fox, C.B (2024). "Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA + GLA-3M-052 liposomes) in rhesus macaques." Human Vaccines and Immunotherapies. 20(1): 2374147 (13 pages).

  4. Chen, J.Z, Finlay, W.H., Vehring, R., and Martin, A.R. (2024). "Characterizing regional drug delivery within the nasal airways." Expert Opinion on Drug Delivery. 21(4): 537-551.

  5. Christianson, C.D., Violato, E., Sabz, M., Rouhani, H., Waring, T., and Martin, A.R. (2024). "Improving breath detection from pulsed-flow oxygen sources using a new nasal interface: a healthy participant study." Respiratory Care. 69(7): 782-789.

  6. Minootan, Z., Wang, H., Connaughton, P. Lachacz, K., Carrigy, N., Ordoubadi, M., Lechuga-Ballesteros, D., Martin, A.R., and Vehring, R. (2024). "On the feasibility of rugose lipid microparticles in pressurized metered dose inhalers with established and new propellants." AAPS PharmSciTech. 25, 82 (16 pages).

  7. Sabz, M., Noga, M.L., Finlay, W.H., Rouhani, H., and Martin, A.R. (2024). "High-flow and low-flow oxygen delivery by nasal cannula evaluated in infant and adult airway replicas." Respiratory Care. 69(4): 438-448.

  8. Seo, S., Ruzycki, C.A., Finlay, W.H., Romanyk, D.L., and Martin, A.R. (2023) "Size-specific filtration efficiency and pressure drop of school-aged children's woven and nonwoven masks at varying face velocities." American Journal of Infection Control. 51(8): 912-918.

  9. Ruzycki, C.A., Pawluski, D., Wong, E.Y.L., Finlay, W.H., and Martin, A.R. (2023) "Provocative dose determination for methacholine challenge test aerosols through in vitro-in silico methods." Journal of Aerosol Science. 171: 106184 (16 pages).

  10. Sabz, M., Tavernini, S., Pillay, K., Christianson, C., Noga, M., Finlay, W.H., Rouhani, H., and Martin, A.R. (2022) "Variability in low-flow oxygen delivery by nasal cannula evaluated in neonatal and infant airway replicas." Respiratory Research. 23: 333 (10 pages).

  11. Tavernini, S., Farnina, D.J., Martin, A.R., and Finlay, W.H. (2022) "Using filters to estimate regional lung deposition with pressurized metered dose inhalers." Pharmaceutical Research. 39: 3371-3380.

  12. Chen, J.Z., Finlay, W.H., and Martin, A.R. (2022) "In vitro regional deposition of nasal sprays in an idealized nasal inlet: comparison with in vivo gamma scintigraphy." Pharmaceutical Research. 39: 3021-3028.

  13. Murphy, B.M., Chen, J.Z., Rolo, M., Eldam, M., Jordan, L., Sivanatham, S.J., Kinsey, R., Guderian, J.A., Pedersen, K., Abhyankar, M., Petri, W.A., Fox, C.B., Finlay, W.H., Vehring, R., and Martin, A.R. (2022) "Intranasal delivery of a synthetic Entamoeba histolytica vaccine containing adjuvant (LecA + GLA-3M-052 liposomes): in vitro characterization." International Journal of Pharmaceutics. 626: 122141 (10 pages).

  14. Ruzycki, C.A., Tavernini, S., Martin, A.R., and Finlay, W.H. (2022) "Characterization of dry powder inhaler performance through experimental methods." Advanced Drug Delivery Reviews. 189: 114518 (19 pages).

  15. Martin, A.R. and Finlay, W.H. (2022). "Empirical deposition correlations." Journal of Aerosol Medicine and Pulmonary Drug Delivery. 35(3): 109-120. Reprinted from The International Society for Aerosols in Medicine Textbook.

  16. Finlay, W.H., Farina, D.J., Tavernini, S., and Martin, A.R. (2022) "In vitro estimation of tracheobronchial and alveolar doses using filters." Frontiers in Drug Delivery – Respiratory Drug Delivery. 2: 901289 (7 pages).

  17. Wang, H., Ordoubadi, M., Connaughton, P., Lachacz, K., Carrigy, N., Tavernini, S., Martin, A.R., Finlay, W.H., Lechuga-Ballesteros, D., and Vehring, R. (2022) "Spray dried rugose lipid particle platform for respiratory drug delivery." Pharm Res. 39: 805-823.

  18. Christianson, C., Pillay, K., Chen, J., Finlay, W.H., and Martin, A.R. (2022) "In Vitro Evaluation of a Nasal Interface Used to Improve Delivery From a Portable Oxygen Concentrator." ASME J Medical Devices. 16(1): 011101 (9 pages).

  19. Seo, S., Ruzycki, C.A., Johnson, B., Wang, H., Vehring, R., Romanyk, D., Finlay, W.H., and Martin, A.R. (2022). "Size-Specific Filtration Performance of N95 Respirators After Decontamination by Moist Heat." Journal of Aerosol Medicine and Pulmonary Drug Delivery. 35(1): 41-49.

  20. Farnoud, A., Tofighian, H., Baumann, I., Martin, A.R., Rashidi, M.M., Menden, M.P., Schmid, O. (2021). "Pulsatile Bi-directional Aerosol Flow Affects Aerosol Delivery to the Intranasal Olfactory Region: A Patient-Specific Computational Study." Frontiers in Pharmacology, Translational Pharmacology. 12:746420 (17 pages).

  21. Duong, K., Noga, M., MacLean, J.E., Finlay, W.H., and Martin, A.R. (2021). "Comparison of airway pressures and expired gas washout for nasal high flow versus CPAP in child airway replicas." Respiratory Research. 22: 289 (13 pages)

  22. Tavernini, S., Farina, D.J., Martin, A.R., and Finlay, W.H. (2021) "Using Filters to Estimate Regional Lung Deposition with Dry Powder Inhalers." Pharmaceutical Research. 38: 1601-1613.

  23. Clapp, P.W., Ruzycki, C.A., Samet, J.M., Zeman, K.L., Bernsten, J., Sickbert-Bennett, E., Anderson, D.J., Weber, D.J., Finlay, W.H., Martin, A.R., Bennett, W.D., and Wilson, K.H. (2021) "A simple homemade HEPA filtering facepiece." American Journal of Infection Control. 49(9): 1206-1209.

  24. Martin, A.R. (2021) "Regional Deposition: Targeting." Journal of Aerosol Medicine and Pulmonary Drug Delivery. 34(1): 1-10. Reprinted from The International Society for Aerosols in Medicine Textbook.

  25. Duong, K., Glover, J., Perry, A.C., Olmstead, D., Ungrin, M., Colarusso, P., MacLean, J.E., and Martin, A.R. (2021) "Feasibility of 3-dimensional facial imaging and printing for producing customized nasal masks for continuous positive airway pressure." ERJ Open Research. 7: 00632-2020.

  26. Chen, J.Z., Martin, A.R., and Finlay, W.H. (2021) "Recent advances in understanding of intranasal drug delivery in vitro and in silico". Current Pharmaceutical Design. 27(12): 1482-1497.

  27. Pillay, K., Chen, J.Z., Finlay, W.H., and Martin A.R. (2021) "Inhaled nitric oxide: in vitro analysis of continuous flow noninvasive delivery via nasal cannula." Respiratory Care, 66(2): 228-239.

  28. Ruzycki, C.A., Murphy, B., Nathoo, H., Finlay, W.H., and Martin A.R. (2020) "Combined in vitro-in silico approach to predict deposition and pharmacokinetics of budesonide dry powder inhalers." Pharmaceutical Research, 37: 209 (19 pages)

  29. Moore, C., Rebstock, D., Katz, I.M., Noga, M.L., Caillibotte, G., Finlay, W.H., and Martin A.R. (2020) "The influence of flowrate and gas density on positive airway pressure for high flow nasal cannula applied to infant airway replicas." Journal of Biomechanics, 112: 110022 (7 pages).

  30. Fink, J.B., Ehrmann, S., Li, J., Dailey, P., McKiernan, P., Darquenne, C., Martin, A.R., Rothen-Rutishauser, B., Kuehl, P.J., Haeussermann, S., MacLoughlin, R., Smaldone, G., Mullinger, B., Corcoran, T., and Dhand, R. (2020) "Reducing medical aerosol-related risk of transmission in the era of COVID-19: an interim guidance endorsed by the International Society for Aerosols in Medicine." Journal of Aerosol Medicine and Pulmonary Drug Delivery, 33(6): 300-304.

  31. Chen, J.Z., Kiaee, M., Martin, A.R. and Finlay, W.H. (2020) “In vitro assessment of an idealized nose for nasal spray testing: comparison with regional deposition in realistic nasal replicas.” International Journal of Pharmaceutics. 119341 (8 pages).

  32. Ruzycki, C.A., Martin, A.R. and Finlay, W.H. (2019) “An exploration of factors affecting in vitro deposition of pharmaceutical aerosols in the Alberta Idealized Throat.” Journal of Aerosol Medicine and Pulmonary Drug Delivery, 32(6): 405-417.

  33. Katz, I., Chen, J., Duong, K., Zhu, K., Pichelin, M., Caillibotte, G., and Martin, A.R. (2019) “Dose variability of supplemental oxygen therapy with open patient interfaces based on in vitro measurements using a physiologically realisitc upper airway model.” Respiratory Research, 20: 149 (12 pages).

  34. Tavernini, S., Kiaee, M., Farina, D.J., Martin, A.R., and Finlay, W.H. (2019) “Development of a filter that mimics tracheobronchial deposition of respirable aerosols in humans.” Aerosol Science and Technology, 53(7): 802-816.

  35. Moore, C.P., Katz, I.M., Pichelin, M., Caillibotte, G., Finlay, W.H., and Martin, A.R. (2019) “High flow nasal cannula: Influence of gas type and flow rate on airway pressure and CO2 clearance in adult nasal airway replicas.” Clinical Biomechanics, 65: 73-80.

  36. Ly, A., Carrigy, N.B., Wang, H., Harrison, M., Sauvageau, D., Martin, A.R., Vehring, R., and Finlay, W.H. (2019) “Atmospheric spray freeze drying of sugar solution with phage D29.” Frontiers in Microbiology, 10:488 (11 pages).

  37. Kiaee, M., Wachtel, H., Noga, M.L., Martin, A.R., and Finlay, W.H. (2019) "An idealized geometry that mimics average nasal spray deposition in adults: A computational study." Computers in Biology and Medicine. 107: 206-217.

  38. Chen, J.Z., Katz, I.M., Pichelin, M., Zhu, K., Caillibotte, G., Finlay, W.H., and Martin, A.R. (2019) "In vitro-in silico comparison of pulsed oxygen delivery from portable oxygen concentrators versus continuous flow oxygen delivery." Respiratory Care. 64(2): 117-129.

  39. Paxman, T., Noga, M., Finlay, W.H., and Martin, A.R. (2019) "Experimental evaluation of pressure drop for flows of air and heliox through upper and central conducting airway replicas of 4- to 8-year-old children." Journal of Biomechanics. 82: 134-141.

  40. Moore, C.P., Katz, I.M., Caillibotte, G., Finlay, W.H., and Martin, A.R. (2019) "Correlation of high flow nasal cannula outlet area with gas clearance and pressure in adult upper airway replicas." Clinical Biomechanics. 66: 66-73.

  41. Martin, A.R., Moore, C.P., and Finlay, W.H. (2018) "Models of deposition, pharmacokinetics, and intersubject variability in respiratory drug delivery." Expert Opinion on Drug Delivery. 15(12): 1175-1188.

  42. Zapol, W.M., Charles, H.C., Martin, A.R., Sa, R.C., Yu, B., Ichinose, F., MacIntyre, N., Mammarappallil, J., Moon, R., Chen, J.Z., Geier, E.T., Darquenne, C., Prisk, G.K. and Katz, I.M. (2018) "Pulmonary delivery of therapeutic and diagnostic gases." Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31(2): 78-87.

  43. Kiaee, M., Wachtel, H., Noga, M.L., Martin, A.R. and Finlay, W.H. (2018) "Regional deposition of nasal sprays in adults: a wide ranging computational study." International Journal for Numerical Methods in Biomedical Engineering. 34: e2968 (13 pages).

  44. Ruzycki, C.A., Martin, A.R., Vehring, R., and Finlay, W.H. (2018) "An in vitro examination of the effects of altitude on dry powder inhaler performance." Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31(4):221-236.

  45. Tavernini, S., Church, T.K., Lewis, D.A., Martin, A.R. and Finlay, W.H. (2018) "Scaling an idealized infant airway geometry to mimic inertial filtration of neonatal nasal airways." Journal of Aerosol Science. 118: 14-21.

  46. Tavernini, S., Church, T.K., Lewis, D.A., Noga, M., Martin, A.R. and Finlay, W.H. (2018) "Deposition of micrometer-sized aerosol particles in neonatal airway replicas." Aerosol Science and Technology. 52(4): 407-419.

  47. Martin, A.R., and Finlay, W.H. (2018) "Model calculations of regional deposition and disposition for single doses of inhaled liposomal and dry powder ciprofloxacin." Journal of Aerosol Medicine and Pulmonary Drug Delivery. 31(1): 49-60.

  48. Chen, J.Z., Katz, I.M., Pichelin, M., Zhu, K., Caillibotte, G., Noga, M.L., Finlay, W.H., and Martin, A.R. (2017) “Comparison of pulsed vs. continuous oxygen delivery using realistic adult nasal airway replicas.” International Journal of COPD. 12: 2559-2571.

  49. Litwin, P.D., Reis Dib, A.L., Chen, J., Noga, M., Finlay, W.H., and Martin, A.R. (2017) "Theoretical and experimental evaluation of the effects of an argon gas mixture on the pressure drop through adult tracheobronchial airway replicas." Journal of Biomechanics. 58:217-221.

  50. Wee, W., Tavernini, S., Martin, A.R., Amirav, I., Majaesic, C., and Finlay, W.H. (2017) “Dry powder inhaler delivery of tobramycin in in vitro models of tracheostomized children.” Journal of Aerosol Medicine and Pulmonary Drug Delivery. 30:64-70.

  51. Katz, I., Pichelin, M., Montesantos, S., Kang, M.-Y., Sapoval, B., Zhu, K., Thevenin, C.-P., McCoy, R., Martin, A.R., and Caillibotte, G. “An in silico analysis of oxygen uptake of a mild COPD patient during rest and exercise using a portable oxygen concentrator.” (2016) International Journal of COPD. 11:2419-2426.

  52. Martin, A.R., Jackson, C., Fromont, S., Pont, C., Katz, I.M., and Caillibotte, G. “An injection and mixing element for delivery and monitoring of inhaled nitric oxide.” (2016) Biomedical Engineering Online. 15:103 (14 pages).

  53. Darquenne, C., Fleming, J., Katz, I., Martin, A.R., Schroeter, J., Usmani, O.S., Venegas, J., and Schmid, O. (2016) “Bridging the gap between science and clinical efficacy: Physiology, imaging, and modeling of aerosols in the lung.” Journal of Aerosol Medicine and Pulmonary Drug Delivery. 29:107-126.

  54. Greenblatt, E.E., Winkler, T., Harris, R.S., Kelly, V.J., Kone, M., Katz, I., Martin, A., Caillibotte, G., Hess, D.R., and Venegas, J. (2016) “Regional ventilation and aerosol deposition with helium-oxygen in bronchoconstricted asthmatic lungs.” Journal of Aerosol Medicine and Pulmonary Drug Delivery. 29:260-272.

  55. Katz, I.M., Palgen, M., Murdock, J., Martin, A.R., Farjot, G., and Caillibotte, G. (2016) “Gas transport during in vitro and in vivo preclinical testing of inert gas therapies.” Medical Gas Research. 6(1): 14-19.

  56. Carrigy, N.B., Carey, J.P., Martin, A.R., Remmers, J.E., Zareian, A., Topor, Z., Grosse, J., Noga, M., and Finlay, W.H. (2016) “Simulation of muscle and adipose tissue deformation in the passive human pharynx.” Computer Methods in Biomechanics and Biomedical Engineering. 19(7): 780-788.

  57. Greenblatt, E.E., Winkler, T., Harris, R.S., Kelly, V.J., Kone, M., Katz, I., Martin, A.R., Caillibotte, G., and Venegas, J. (2016) “What causes uneven aerosol deposition in the bronchoconstricted lung? A quantitative imaging study.” Journal of Aerosol Medicine and Pulmonary Drug Delivery. 29(1): 57-75.

  58. Wei, J., Tang, J.W., Borojeni, A.A.T., Yin, S., Martin, A., Finlay, W.H., and Li, Y. (2016) “Low re-inhalation of the exhaled flow during normal nasal breathing in a pediatric airway replica.” Building and Environment. 97: 40-47.

  59. Carrigy, N.B., Martin, A.R., and Finlay, W.H. (2015) "Use of extrathoracic deposition models for patient-specific dose estimation during inhaler design." Current Pharmaceutical Design. 21(27): 3984-3992.

  60. Haussermann, S., Schulze, A., Katz, I.M., Martin, A.R., Herpich, C., Hunger, T., and Texereau, J. (2015) "Effects of a helium/oxygen mixture on individuals' lung function and metabolic cost during submaximal exercise for participants with obstructive lung diseases." International Journal of Chronic Obstructive Pulmonary Disease. 10(1): 1987-1997.

  61. Borojeni, A.A.T., Noga, M.L., Martin, A.R., and Finlay, W.H. (2015) “Validation of airway resistance models for predicting pressure loss through anatomically realistic conducting airway replicas of adults and children.” Journal of Biomechanics. 48: 1988-1996.

  62. Borojeni, A.A.T., Noga, M.L., Martin, A.R., and Finlay, W.H. (2015) “An idealized branching airway geometry that mimics average aerosol deposition in pediatric central conducting airways.” Journal of Aerosol Science. 85: 10-16.

  63. Clark, A., Rossmann, J.S., Katz, I.M., Martin, A.R., and Caillibotte, G. (2015). “Pressure loss coefficients for asymmetric bifurcations with predetermined flow distributions.” Journal of Bioengineering & Biomedical Science. 5:1 (6 pages).

  64. Sarracanie, M., Grebenkov, D., Sandeau, J., Coulibaly, S., Martin, A.R., Hill, K., Sanchez, J.M.P., Fodil, R., Martin, L., Durand, E., Caillibotte, G., Isabey, D., Darrasse, L., Bittoun, J., and Maitre, X. (2015) “Phase-contrast helium-3 MRI of aerosol deposition in human airways.” NMR in Biomedicine, 28(2):180-187.

  65. Martin, A.R., and Finlay, W.H. (2015) “Nebulizers for drug delivery to the lungs” Expert Opinion on Drug Delivery. 12(6): 889-900.

  66. Gouinaud, L., Katz, I., Martin, A.R., Hazebroucq, J., Texereau, J., and Caillibotte, G. (2015) “Inhalation pressure distributions for medical gas mixtures calculated in an infant airway morhphology model.” Computer Methods in Biomechanics and Biomedical Engineering, 18(12): 1359-1366.

  67. Martin, A.R., Jackson, C., Katz, I.M., and Caillibotte, G. (2014) “Variability in uptake efficiency for pulsed versus constant concentration delivery of inhaled nitric oxide.” Medical Gas Research, 4:1 (13 pages).

  68. Katz, I., Pichelin, M., Montesantos, S., Majoral, C., Martin, A., Conway, J., Fleming, J., Venegas, J., Greenblatt, E., and Caillibotte, G. (2014) “Using helium-oxygen to improve regional deposition of inhaled particles: mechanical principles.” Journal of Aerosol Medicine and Pulmonary Drug Delivery, 27: 71-80.

  69. Martin, A.R., Katz, I.M., Lipsitz, Y., Terzibachi, K., Caillibotte, G., and Texereau, J. (2012) “Methods for evaluating helium/oxygen delivery through non-rebreather facemasks.” Medical Gas Research. 2:31 (11 pages).

  70. Martin, A.R., Katz, I.M., Jenöfi, K.., Caillibotte, G., Brochard, L., and Texereau, J. (2012) “Bench experiments comparing simulated inspiratory effort when breathing helium-oxygen mixtures to that during positive pressure support with air.” BMC Pulmonary Medicine. 12:62 (10 pages).

  71. Martin, A.R., Katz, I.M., Terzibachi, K., Gouinaud, L., Caillibotte, G., and Texereau, J. (2012) “Bench and mathematical modeling of the effects of heterogeneous airway obstructions on compartmental and whole-lung expiratory time constants while breathing a helium/oxygen mixture versus air.” Biomedical Engineering Online. 11:27 (15 pages).

  72. Conway, J.H., Fleming, J.S., Majoral, C., Katz, I., Perchet, D., Peebles, C., Tossici-Bolt, L., Collier, L., Caillibotte, G., Pichelin, M., Sauret-Jackson, V., Martonen, T., Apiou-Sbirlea, G., Muellinger, B., Kroneberg, P., Gleske, J., Scheuch, G., Texereau, J., Martin, A., Montesantos, S., and Bennett, M. (2012) “Controlled, parametric, individualized, 2-D and 3-D imaging measurements of aerosol deposition in the respiratory tract of healthy human subjects for model validation.” J. Aerosol Sci. 52: 1-17.

  73. Katz, I.M., Martin, A.R., Feng, C.-H., Majoral, C., Caillibotte, G., Marx, T., Bazin, J.-E., and Daviet, C. (2012) “Airway pressure distribution during xenon anesthesia: the insufflation phase at constant flow (volume controlled mode).” Applied Cardiopulmonary Pathophysiology. 16: 5-16.

  74. Irani, Y., Pype, J.L., Martin A.R., Chong, C.F., Daniel, L., Gaudart, J., Ibrahim, Z., Magalon, G., Lemaire, M., and Hardwigsen, J. (2011) “Nobel gas (argon and xenon) saturated cold storage solutions reduce ischemia-reperfusion injury in a rat model of renal transplantation.” Nephron Extra. 1: 272-282.

  75. Katz, I.M., Caillibotte, G., Martin, A.R., and Arpentinier, P. (2011) “Property value estimation for inhaled therapeutic binary gas mixtures: He, Xe, N2O, and N2 with O2.” Medical Gas Research. 1:28 (12 pages).

  76. Martin, A.R., Ang, A., Katz, I.M., Haussermann, S., Caillibotte, G., and Texereau, J. (2011) “An in vitro assessment of aerosol delivery through patient breathing circuits used with medical air or a helium-oxygen mixture.” Journal of Aerosol Medicine and Pulmonary Drug Delivery. 24: 225-234.

  77. Katz, I.M., Martin, A.R., Muller, P.-A., Terzibachi, K., Feng, C.-H., Caillibotte, G., Sandeau, J., and Texereau, J. (2011) “The ventilation distribution of helium-oxygen mixtures and the role of inertial losses in the presence of heterogeneous airway obstructions.” Journal of Biomechanics. 44: 1137-1143.

  78. Redman, G.E.S., Martin, A.R., Waszak, P., Thompson, R., Cheung, P.-Y., Thébaud, B., and Finlay, W.H. (2011) “Pilot study of inhaled aerosols targeted via magnetic alignment of high aspect ratio particles in rabbits.” Journal of Nanomaterials. Article ID 130721 (7 pages).

  79. Martin, A.R., Gleske, J., Katz, I.M., Hartmann, M., Mullinger, B., Haussermann, S., Caillibotte, G., and Scheuch, G. (2010) “Laser diffraction characterization of droplet size distributions produced by vibrating mesh nebulization in air and a helium–oxygen mixture.” Journal of Aerosol Science. 41: 1159-1166.

  80. Martin, A.R., Thompson, R.B., and Finlay, W.H. (2008) “MRI measurement of regional lung deposition in mice exposed nose-only to nebulized superparamagnetic iron oxide nanoparticles.” Journal of Aerosol Medicine and Pulmonary Drug Delivery. 21: 335-342.

  81. Martin, A.R., and Finlay, W.H. (2008). “Enhanced deposition of high aspect ratio aerosols in small airway bifurcations using magnetic field alignment.” Journal of Aerosol Science. 39: 679-690.

  82. Martin, A.R., and Finlay, W.H. (2008). “Magnetic alignment of aerosol particles for targeted pulmonary drug delivery: comparison of magnetic and aerodynamic torques.” Journal of Computational and Theoretical Nanoscience. 5: 2067-2070.

  83. Finlay, W.H., and Martin, A.R. (2008). “Recent advances in predictive understanding of respiratory tract deposition.” Journal of Aerosol Medicine. 21: 189-206.

  84. Martin, A.R., and Finlay, W.H. (2008). “Alignment of magnetite loaded high aspect ratio aerosol drug particles with magnetic fields.” Aerosol Science and Technology. 42: 295-298.

  85. Martin, A.R., and Finlay, W.H. (2007). “A general, algebraic equation for predicting total respiratory tract deposition of micrometer-sized aerosol particles in humans.” Journal of Aerosol Science. 38: 246-253.

  86. Finlay, W.H., and Martin, A.R. (2007). “Modeling of aerosol deposition with interface devices.” Journal of Aerosol Medicine. 20, Supplement 1: S20-S27.

  87. Grgic, B., Martin, A.R., and Finlay, W.H. (2006). “The effect of unsteady flow rate increase on in vitro mouth-throat deposition of inhaled boluses.” Journal of Aerosol Science. 37: 1222-1233.

  88. Martin, A.R., and Finlay, W.H. (2005). “The effect of humidity on the size of particles delivered from metered-dose inhalers.” Aerosol Science and Technology. 39: 283-289.

  89. Martin, A.R., Kwok, D.Y., and Finlay, W.H. (2005). “Investigating the evaporation of metered-dose inhaler formulations in humid air: single droplet experiments.” Journal of Aerosol Medicine. 18(2): 218-224.

Articles in Trade Magazines

  1. Martin, A.R., Ruzycki, C.A., Tavernini, S., and Finlay, W.H. (2023) "In vitro methods to predict total and regional lung deposition of orally inhaled products." Inhalation Magazine. August 2023.

  2. Martin, A.R., and Finlay, W.H. (2015) “Evaluating inhaler performance using idealised throats.” European Pharmaceutical Review, 20: 55-57.

Book Chapters

  1. Ruzycki, C.A., Finlay, W.H., and Martin, A.R. (2022) “Estimating Clinically Relevant Measures of Inhaled Pharmaceutical Aerosol Performance with Advanced In Vitro and In Silico Methods.” In Narang, A. and Mahato, R. (Ed.), Organ Specific Drug Delivery and Targeting to the Lungs. CRC Press, Taylor & Francis Group.

  2. Martin, A.R. (2015) “Deposition of Aerosols in the Lungs: Regional Deposition – Targeting.” In R. Dhand (Ed.), ISAM Textbook of Aerosol Medicine, pp. 59-82. International Society for Aerosols in Medicine.

  3. Martin, A.R., and Finlay, W.H. (2015) “In Vitro Testing of Pharmaceutical Aerosols and In Vitro/In Vivo Correlations: Empirical Deposition Correlations.” In R. Dhand (Ed.), ISAM Textbook of Aerosol Medicine, pp. 253-282. International Society for Aerosols in Medicine.

  4. Martin, A.R., and Finlay, W.H. (2012) “Aerosol drug delivery to the lungs.” In S.C. Gad (Ed.), Development of Therapeutic Agents Handbook, pp. 565-588. John Wiley & Sons, Inc., Hoboken, New Jersey.

Granted Patents

  1. Finlay, W.H., Ruzycki, C.A., Martin, A.R., Ayranci, C., and Tavernini, S.E. (2023). “Filters for mimicking regional lung deposition.” US11740161 B2.

  2. Martin, A. (2019). “Nasal cannula assembly with flow control passage communicating with a deformable reservoir.” US10293132 B2.

  3. Martin, A. (2018). “Breathing assistance apparatus with nasal cannula assembly communicating with a deformable reservoir.” EP3041559 B1.

  4. Martin, A. (2017). “Nasal cannula assembly with flow control passage communicating with a deformable reservoir.” US9566407 B2.

  5. Martin, A. (2016). “Method of treating a patient having pulmonary hypertension by long term NO therapy.” US9522247 B2.

  6. Martin, A. (2016). “Breathing assistance apparatus for delivery of nitric oxide to a patient by means of a nasal cannula assembly with flow control passage.” US9522248 B2.

  7. Martin, A. (2016). “Method of delivering medical gases via a nasal cannula assembly with flow control passage communicating with a deformable reservoir.” US9517318 B2.

  8. Martin, A. (2016). “Breathing assistance assemblies suitable for long term NO therapy.” US9492626 B2.

  9. Martin, A. (2016). “Nasal cannula assembly with inhalation valves communicating with a deformable reservoir.” US9486600 B2.

  10. Martin, A., Katz, I., Daviet, C., and Texereau, J. (2015). “Gas distribution device with a loop circuit and buffer tank.” EP2800601 B1.

  11. Daviet, C., Katz, I., Martin,A., and Texereau, J. (2014). “Dispositif de distribution de gaz a circuit en boucle et reservoir-tampon.” FR2985191 B1.

  12. Martin, A., Pype, J., Chong, C.F., and Lemaire, M. (2014). “Formulation liquide avec gaz dissous utilisable pour conserver de la matiere biologique.” FR2956289 B1.

  13. Katz, I., Martin, A., Caillibotte, G., and Texereau, J. (2014). “Appareil pour evaluer et identifier un patient susceptible de beneficier d’une therapie helium-oxygene.” FR2989262 B1.